(Received for publication July 6, 1981) The synthesis and in vitro activity of 7-vinylenethioacetamido cephalosporins with a tetrazolo-pyridazine at the 3-position are described. These cephalosporins showed good activity against Gram-positive and Gram-negative bacteria.
7-[(Z)-i3-Carboxyvinylenethioacetamido]-3-[(tetrazolo[1,5-b]pyridazin-8-amino-6-yl)-thiomethyl]-3-cephem-4-carboxylic acid
(K 13176, 21) was significantly more active in vitro and in vivo than cefazolin against Gramnegative bacteria.
An earlier paper') described the synthesis of 7-vinylenethioacetamido cephalosporins and their analogues with five-membered heterocycles at the 3-position. The antibacterial activity of these cephalosporins varied considerably depending on the functional group introduced in the 7-side chain, the stereochemistry of the double bond and the heterocycle at the 3-position. Of these, 7-[(Z)-13-cyanovinylenethioacetamido-3-(1-methyl-lH-tetrazol-5-yl)-thiomethyl]-3-cephem-4-carboxylic acid (K 13101) was several times more active in vitro than cefazolin, but its in vivo activity was equal to or only slightly higher.
As an extension of our program to improve R -CH=CH-S-CH2CONH S both the antibacterial activity and pharmacokio N s-e netic properties, we decided to pursue our initial COON approach in the 7-vinylenethioacetamido cepha-R = CN, CONH2, COOR1 (R1= H, CH3, CA) l osporins synthesizing a series of compounds with a tetrazolo [1,5-b] pyridazine at the 3-position-).
Q= Tetrazolo [1,5-b] pyridazine This paper describes the synthesis of these new cephalosporins, the preparation of the new bicyclic heteroaromatic thiols and the results of our structure-activity studies.
Chemistry
Some of the side chain acids (R=CN, CONH2, COOH) have already been reported in our previous paper).
Our first approach to synthesizing the others (RCOOCH" COOC.H,) by addition of thioglycolic acid to methyl or ethyl propiolate, according to the procedure previously described'), afforded only a mixture of (Z)-and (E)-isomers (60: 40), from which the pure (Z)-isomer was obtained by crystallization of the dicyclohexylamine salt and subsequent release of the free acid by treatment with H.,PO,. This process suffered from poor stereoselectivity and yield (about 28%). VOL. XXXiV NO. 11 THE JOURNAL OF ANTIBIOTICS Better results were achieved with an alternative synthesis (Scheme 1), in which tert-butylthioglycolate was added stereoselectively to propiolic acid, affording only the (Z)-isomer (1) in a high yield, which was then converted to the acyl chloride (2) by treatment with phosphorus pentachloride in ethyl ether. Reaction with sodium methoxide or ethoxide in a mixture of ethyl ether and methanol or ethanol gave 3 or 4 respectively. The final step of the process was to remove the tort-butyl group with trifluoroacetic acid to obtain the free acids 5 or 6.
Bicyclic heteroaromatic thiols used in our study were prepared as reported in Scheme 2
and are listed in Table 1 .
Scheme 1. Substituted vinylenethioacetic acids.
The intermediates 8-11 were partly already known from the literature; the unknown ones were prepared following procedures in the literature, which were modified in some cases (see Experimental).
Refluxing 1,2-dihydropyridazin-3,6-dione 7 (a, b) with POCI3 gave 3,6-dichloropyridazines 8 (a, b).
In the case of 8c we modified the synthesis reported in literature3) and studied an alternative method in order to avoid the irritant 3,4,6-trichloropyridazine. For this purpose we started from 4-amino-l,2-dihydropyridazin-3,6-dione, and converted it to 8c by heating with POCI3 at 120°C in a sealed tube.
Refluxing with POC13 gave only 4-amino-6-chloro-pyridazin-3(2H)-one.
By a similar procedure 4-methylamino-1,2-dihydropyridazin-3,6-dione was chlorinated with POCI;, to give 8d which proved identical to that described in the literature'). (10) HOHC-C=CH-HSCH2C00-t-ru 1 R= COON, 3 P.= COOCH3 2 P = COC , 4 P = COOC2H5
5 P-COOCH3 Refluxing 8(a-d, f, g) with hydrazine hydrate in ethanol gave 9a''. 9b", 9c°', 9d", 9f and 9g`1 respectively.
Reaction of 9 (a-d, f, g) with sodium nitrite in mineral acid gavel0a", 10b", We"', 10d, 10fand 10g.
Treatment of 10c with bromoacetic acid and NaH in DMSO gave 10e.
Compounds 10 (a-g) were converted to the corresponding thiols 11 (a"', b-g ) by reaction with alkali hydrogen sulfide in water or ethanol (see Experimental).
Cyclization of 9h with sodium nitrite in hydrochloric acid gave 10h'"), which was then converted to
Ilh by reaction with potassium hydrogen sulfide.
Nucleophilic displacement of the C-3 acetoxy group of 7-ACA with the bicyclic thiols (11) was achieved in the usual manner"', also outlined in the Experimental Section to give 12 ( Table 2 ).
The structure of these derivatives was established by their infrared spectra (3-lactam C0 absorption at 1770 1805 cm-') and UV maxima at 260-275 nrn due to the cephem nucleus and that due to the heterobicyclic ring in the C-3 side chain.
The cephalosporins were prepared by acylating 12 with ,G-substituted vinylenethioacetic acids (Scheme 3). Acylation was carried out using mixed anhydride derived from pivaloyl chloride (method A). When a second carboxyl group was present in the acylating acid (R=COOH), this was protected as its tert-butyl ester, which was subsequently removed with trifluoroacetic acidanisole (method B).
The cephalosporins synthesized are listed in Table 3 . The purity of the cephalosporins, established by NMR, TLC, and analyses, was greater than 90%.
Antimicrobial Activity
The minimum inhibitory concentrations (MICs) of this series of cephalosporins against 3 strains of
Gram-positive and 6 strains of Gram-negative bacteria were determined by the standard two-fold serial dilution method using diagnostic sensitivity test agar (Oxoid). The plates were inoculated with about 2;:10' colony forming units using an automatic inoculator (Denley Tech. Ltd.). The results are the geometric average of two determinations and are compared with cefazolin (CEZ) . Determined in 1 % NaHCO, solution. Determined in 1 % NaOH solution. ' All compounds were analysed for C , H, N, S. Analytical results are coincident with the calculated value within -0.50% deviation. Table  2 .
Gram-positive and Gram-negative bacteria than the corresponding (E) isomers (13, 14 and 15) . Substitution of the -CN group (13,16 and 19) either with -CONH. (14,17 and 20) or -000H (15,18 and 21) led in general to reduced activity against Gram-positive bacteria.
The only exception was Streptococcus pyogenes C 203, against which substitution of the -CN group with -CONH2 maintained the activity constant (14, 17, 20) . The effect on the activity against Gram-negative bacteria was variable.
In the series of unsubstituted tetrazolo [1,5-b] In view of their activity, derivatives containing the -CN group were selected for further modifications at the 3-position. Table 5 summarizes the activity of all the 7-(Z)-(S-cyanovinylenethioacetamido cephalosporins synthesized. The modifications on the hcterobicyclic ring had various effects on the activity. Introduction of an amino group (c) enhanced (with some exceptions) the activity against both
Gram-positive and Gram-negative bacteria, while the other modifications (2226) dramatically reduced the activity especially against Gram-negative bacteria. 27 was less active than its isomer 19. Sb.s. a See footnote a to Table 4 . b See Scheme 3 . The most active compounds were tested in rivo in mice against experimental infections with Staphylococcus aurerrs Smith and Escherichia coli G according to the following method: male albino CD-I COBS mice (18-20 g) were infected intraperitoneally with bacterial suspensions in amounts corresponding to the LD90. Treatments were given subcutaneously immediately after the infection and 3 hours later. A complete balanced block design was followed with random assignment of the drugs (2-4 groups of 7 mice per dose). The animals were kept under observation for 5 days when they had been infected with Gram-negative bacteria and for 7 days when they had been infected with Gram-positives.
From the survival rates the median effective dose (ED;-,n) and the potency ratios between the drugs were calculated by probit analysis').
Of the compounds selected for in vivo evaluation compound 21 proved 23 times more active than cefazolin against Escherichicr coli G and therefore was studied more widely, in comparison with cefazolin, in mice infected with 7 other bacteriae strains. The results are reported in Table 7 .
Against H. influenzae, E. coli, K. pneumoniac, P. mirabilis, P. vcrlgaris and S. typhi Watson, 21 was 6 to 53 times more potent than CEZ. Against Gram-positive bacteria the activity of 21 was equal to that of CEZ.
The superior in vitro activity against Gram-negative bacteria, in comparison with cefazolin, is therefore confirmed by the higher in vivo therapeutic efficacy.
Experimental
Infrared spectra were recorded on a Perkin-Elmer spectrometer (model 125). The NMR spectra were determined on either a Perkin-Elmer R-24 B (60 MHz) or a Bruker HX-90 (90 MHz) spectrometer using tetramethylsilane as internal standard, and chemical shifts are reported in parts per million (o) relative to Me,Si. Melting points were established on a Biichi melting point apparatus and are not corrected. Melting points of the cephalosporins are not accurately reproducible because of extensive decomposition.
(Z _)-,.-Methoxycarbonylvinylenethioacetic Acid (5) A solution of 70% thioglycolic acid (6.4 nil, 60 mmole) in 2 N NaOH (30 ml) and water (23.6 ml) was added dropwise, with stirring, to an ice-cold solution of methylpropiolate (5.3 g, 63 mmole) in acetone (76 nil) and water (38 nil). After stirring for I hour at 0°C and an additional hour at 10'C the acetone was removed in vacuo. Water was added and the reaction mixture was adjusted to pH 9 .9.5 with a few drops of 2 N aqueous NaOH. The aqueous solution was washed with ethyl acetate, acidified with 20% H,SO,, and extracted with ethyl acetate. The organic layer was washed with saturated aqueous VOL. To a stirred suspension of 1 (1.09 g, 5 mmole) in ethyl ether (50 nil), cooled to 0°C, PCI5 (1.04 g, 5 mmole) was added portionwise and the mixture was stirred for 2 hours at 0°C. After evaporation in vacuo below 40°C, the residue was taken up with benzene and evaporated again in vacuo, leaving 2 quantitatively as an almost colorless oil, which was used for the next step without further purification.
To a stirred solution of sodium ethoxide (0.340 g, 5 mmole) in dry ethyl ether (30 ml) and dry ethanol (10 nil), cooled to 0°C, a solution of 2 (1.18 g, 5 mmole) in dry ethyl ether (20 ml) was added dropwise. The mixture was stirred for 15 minutes at 0-5°C and then evaporated in vacuo without heating. The residue was taken up with ethyl ether (30 ml); the organic layer was washed twice with water, dried (Na, SO) and evaporated in vacuo to give 4 quantitatively as a viscous oil; NMR (acetone- A mixture of the above ester 4 (1.2 g, 5 mmole) and trifluoroacetic acid (10 ml), cooled to 0-5°C, was stirred for 30 minutes.
The end of the reaction was determined by TLC (benzene -ethyl acetate -CH., 130: 25: 15: 60 Anal. Calcd for GH100,S: C, 44.20; H, 5.29; S, 16.85. Found: C, 44.32; H, 5.30; S, 16.79 . By a similar procedure 2 was first reacted with sodium methoxide in a mixture of methanol and ethyl ether to give 3, and then converted to 5 (95 % yield based on 2), which was identical to that described above.
4-Amino-3,6-dichloropyridazine (8c) A mixture of 4-amino-1,2-dihydropyridazine-3,6-dione (1.27 g, 10 mmole) and P00, (37 ml) was heated for 15 hours at 120°C in a sealed tube. The excess of POCI, was removed in vacuo at 70°C. The residue was taken up with water (20 ml), stirred for 30 minutes at 50-60°C and filtered hot. The filtrate was cooled to 0-5°C and adjusted to pH 3.5 with 35 % NaOH and stirred for 15 hours at 0-5°C. The solid obtained was filtered, suspended in water (15 ml), made alkaline with 20 % NH,OH and stirred for 1 hour at 0-5°C.
The precipitate was collected, washed with water and dried in vacuo at 70°C to give 1.23 g (75. 3-Hydrazino-4-carboxy-6-chloro-pyridazine (9f) A mixture of 3,6-dichloro-4-carboxy-pyridazine') (1.93 g, 10 mmole) and 98 % hydrazine hydrate (2.16 g, 43.2 mmole) in dry ethanol (15 ml) was refluxed, with stirring, for 1 hour. After cooling to 5"C, the precipitate was collected and washed with cold ethanol. The solid was then suspended in water (10 ml), adjusted to pH 2 with 23 % HCI, stirred for 1 hour at 0-5°C and filtered. The crude product was dissolved in hot water (30 ml), treated with charcoal and filtered. The filtrate was cooled in an ice bath, the resulting precipitate was collected and dried in vacuo at 80°C to give 1.76 g (93.4%) of 9f; mp 198201°C (dec.); NMR (DMSO-d0): 3 7.8 (lH, s, 5-H on pyridazine ring), 9.2 (4H, br-s, -COOH, -NHNH .,).
Anal. Calcd. for C5H;CIN,O2: C, 31.84; H, 2.67; CI, 18.80; N, 29.71. Found: C, 31.64; H, 2.64; Cl, 18.53; N, pyridazine (10f) To an ice-cold suspension of 3-hydrazino-4-carboxy-6-chloro-pyridazine (1.88 g, 10 mmole) in a mixture of 35 % HC1 (2.04 ml) and water (30 ml) a solution of sodium nitrite (0.86 g, 12.5 mmole) in water (3 ml) was added dropwise in 10 minutes. After stirring for 2 hours at 5. 10°C, the separated precipitate was collected, washed with cold water and dried ill vacuo at 80°C to give 1.94 g (97 %) of 10f; mp 222 223°C (dec.); IR (Nujol): 1730 cm-1; NMR (DMSO-d0): 6 8.33 (1H, s, 7-H on pyridazine ring).
Anal. Calcd. for C3H.,CIN,O~: C, 30.09; H, 1.00; CI, 17.76; N, 35.09. Found: C, 29.95; H, 0.98; Cl, 17.58; N, 35.15 . By a similar procedure 10d and 10g were prepared and the data for each compound are as follows: 10d; nip 244246°C (dec.); IR (KBr): 3360, 3260, 2890, 1645, 1088, 980, 720 cm-1.
Anal. Calcd. for C,H"CIN°: C, 32.53; H, 2.73; Cl, 19.21; N, 45.53. Found: C, 32.49; H, 2.77; Cl, 19.22; N, 45.54. 10g; nip 226°C (dec.); IR (KBr): 3410, 3240, 3180, 1700 , 1680 , 1620 , 1080 H, 1,52; Cl, 17.85; N, 42.32. Found: C, 30.11; H, 1.44; CI, 17.69; N, 42.10. 6-Chloro-8-carboxymethylamino-tetrazolo[1,5-b] pyridazine (10e) To an ice-cold solution of 10c'° (17 g, 0.1 mole) in dry DMSO (250 ml) a 50% oil suspension of NaH (0.3 mole) was added portionwise with stirring. When addition was complete, the temperature was allowed to rise to room temperature and a solution of bromoacetic acid (13.9 g, 0.1 mole) in DMSO (50 ml) was added dropwise. After stirring for 48 hours at room temperature, the solvent was removed in vacuo at 0.5. 1 mmHg. The residue was taken up with water (200 nil); the undissolved material was filtered off and discarded. The filtrate was extracted with benzene (3 x 50 nil), the aqueous phase was adjusted to pH 2.5 with 37 jo HCI and the resulting precipitate was collected, washed with water and crystallized from water to give 13.69 g (60%) of 10e; mp 241 -242°C (dec.); IR (KBr): 3380, 3340, 3080, 1720 , 1620 , 1080 THE JOURNAL OF ANTIBIOTICS Anal. Calcd. for C,H;CIN6O3: C, 31.52; H, 2.20; Cl, 15.51; N, 36.76. Found: C, 31.33; H, 2.16; Cl, 15.54; N, pyridazine (11d) A stirred solution of 10d (10 g, 54 mmole) and KSH (9.6 g, 128 mmole) in dry ethanol (100 ml) was refluxed for 5 hours. The reaction mixture was evaporated to dryness and the residue was dissolved in water (150 ml). The solution was clarified with activated carbon, filtered and the filtrate acidified to pH 1 -2 with conc.HCI to precipitate 11d, which was collected by filtration and washed with water.
The crude product was dissolved in 5 % aqueous KHCO3 solution (150 ml), the undissolved material was filtered and discarded. The filtrate was acidified with cone.HCI to give 8.0 g (80%) of pure 11d; mp 230°C (dec.); IR (KBr): 3250, 2475 cm-1; UV (1 % NaHCO, solution) 269 nm (s, 20153); NMR (DMSO-d,); 5 2.98 (3H, d, J=3 Hz, ), 4.10 (1 H, br, -SH), 6.56 (1H, s, 7-H on pyridazine ring), 8.60 (1 H, br, J=3 Hz, .
Anal. Calcd. for C, HEN8S: C, 32.96; H, 3.32; N, 46.13; S, 17.59. Found: C, 32.99; H, 3.28; N, 46.38; S, 17.46 . By a similar procedure lie and llh were prepared and the data for each compound are as follows: 1 le; mp 218-220°C (dec.); IR (KBr); 3280-3100, 3080-3040, 3000. 2300, 2920-2850, 2570, 1720, 1610 -1570, 1440 -1380 To a stirred solution of 75 % NaSH (1.93 g, 25.9 mmole) in water (35 ml) 6-chloro-8-carboxy-tetrazolo [1,5-b] pyridazine (1.99 g, 10 mmole) was quickly added, under N. stream, and the mixture was vigorously stirred for 90 minutes at 2025°C.
The undissolved material was filtered off and discarded; the filtrate was cooled to 0-5'C and adjusted to pH 1 -2 with 23% HCI. The suspension was stirred for 30 minutes at 0'5°C, the solid was collected, washed with water (20 ml) and dried in vacuo at 50°C to give 2.O g (93% To a stirred solution of (Z)-r3-cyanovinylenethioacetic acid (0.72 g, 5 mmole) and triethylamine (0.70 nil) in dry acetone (40 nil), cooled to 0°C, pivaloylchloride (0.61 ml) dissolved in dry acetone (10 ml) was added dropwise. The mixture was stirred for 30 minutes at 0°C, then a solution of 7-amino-3-[(tetrazolo[l,5-b] pyridazin-8-amino-6-yl)-thiomethyl-3-cephem-4-carboxylic acid (1.90g, 5 mmole) and triethylamine (0.7 ml) in 50% aqueous acetone (80 nil) was added dropwise, maintaining the temperature at about 0"C. After stirring for 1 hour at 0` C and 2 hours at room temperature the acetone was removed in vacuo. The residue was taken up with water and washed with ethyl acetate (discarded).
The aqueous phase was cooled, adjusted to pH 2 with 20 H..SO, with stirring and extracted with ethyl acetate.
The undissolved material was filtered off and discarded. The organic layer was separated, washed with aqueous NaCI solution, dried (Na.,SO,) and evaporated to small volume in racuo.
